CrossRef The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation Lili Jiang, Yi Shen, Zhengyang Feng, Yong Wang, Yaqun Zhu, Yuntian Shen, Qiliang Peng European Journal of Medical Research .2025;[Epub] CrossRef The potential of soluble programmed cell death-ligand 1 and soluble programmed cell death 1 as diagnostic and prognostic biomarkers for hepatocellular carcinoma: a meta-analysis Jie Li, Xiangyang He, Tingting Gao, Qingjun Zhang, Xu Han Irish Journal of Medical Science (1971 -) .2025
Adams, MD, JD, MSc Evolutions in endoscopy by GI and Hepatology News Recruiting gastroenterology and hepatology fellows virtually - Should we continue after the pandemic
Volume, Intensity, and Recovery Considerations Emerging research suggests that while high training volume can support hypertrophy in energy-balanced states, it may not confer additional lean mass preservation benefits under calorie restriction (Roth et al., 2022)
And if you do, failure is coming your way
Retrieved March 23, 2009
Semaglutide can be prescribed only to those who meet the following criteria: If you have a body mass index (BMI) of 27 kg/m2 or greater At least one weight-related condition like high blood pressure or high cholesterol Have a BMI of 30 kg/m2 or greater